Intuitive Surgical, Inc. (ISRG)
366.70
-3.13
(-0.85%)
USD |
NASDAQ |
Sep 04, 16:00
366.48
-0.22
(-0.06%)
After-Hours: 20:00
Intuitive Surgical Research and Development Expense (Quarterly) : 370.40M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 370.40M |
| March 31, 2026 | 361.60M |
| December 31, 2025 | 352.90M |
| September 30, 2025 | 329.40M |
| June 30, 2025 | 313.30M |
| March 31, 2025 | 316.20M |
| December 31, 2024 | 294.70M |
| September 30, 2024 | 286.00M |
| June 30, 2024 | 280.10M |
| March 31, 2024 | 284.50M |
| December 31, 2023 | 260.10M |
| September 30, 2023 | 249.40M |
| June 30, 2023 | 243.70M |
| March 31, 2023 | 244.20M |
| December 31, 2022 | 243.40M |
| September 30, 2022 | 216.50M |
| June 30, 2022 | 206.60M |
| March 31, 2022 | 209.80M |
| December 31, 2021 | 177.60M |
| September 30, 2021 | 164.90M |
| June 30, 2021 | 158.30M |
| March 31, 2021 | 159.10M |
| December 31, 2020 | 149.00M |
| September 30, 2020 | 145.00M |
| June 30, 2020 | 140.10M |
| Date | Value |
|---|---|
| March 31, 2020 | 145.20M |
| December 31, 2019 | 153.40M |
| September 30, 2019 | 133.10M |
| June 30, 2019 | 118.00M |
| March 31, 2019 | 142.20M |
| December 31, 2018 | 118.80M |
| September 30, 2018 | 105.60M |
| June 30, 2018 | 93.50M |
| March 31, 2018 | 93.90M |
| December 31, 2017 | 85.60M |
| September 30, 2017 | 81.50M |
| June 30, 2017 | 82.80M |
| March 31, 2017 | 71.50M |
| December 31, 2016 | 66.60M |
| September 30, 2016 | 60.10M |
| June 30, 2016 | 52.20M |
| March 31, 2016 | 50.30M |
| December 31, 2015 | 49.70M |
| September 30, 2015 | 48.00M |
| June 30, 2015 | 46.50M |
| March 31, 2015 | 41.50M |
| December 31, 2014 | 44.80M |
| September 30, 2014 | 44.60M |
| June 30, 2014 | 37.30M |
| March 31, 2014 | 39.80M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Stryker Corp. | 424.00M |
| Zimmer Biomet Holdings, Inc. | 104.80M |
| Abbott Laboratories | 892.00M |
| Boston Scientific Corp. | 554.00M |
| Globus Medical, Inc. | 36.32M |